CHECKIT
John Wilson
CEO
We have worked with Yellowstone Advisory for a number of years and they transformed our investor relations strategy which significantly increased the interest of our business to both institutional and retail investors. We have been impressed by their understanding of the smaller companies market and their results focussed approach to IR. I would recommend their services without hesitation.
EQUINITI
Guy Wakeley
CEO
Yellowstone Advisory provided valuable input into the interim results announcement and presentation, helping to ensure the investment messaging was consistent throughout the documents. Great relationships and credibility with investors enables them to solicit useful feedback which we have used in developing our future investor messaging.
.png){kind=small}
Thu, 15 Aug
|34 Berkeley Square
GSK Company Meeting (1)
Sarah Elton-Farr, Head of Investor Relations, will present the company strategy followed wine by wine and canapes
Time & Location
15 Aug 2019, 17:15 – 21:15
34 Berkeley Square, 34 Berkeley Square, Mayfair, London W1J 5BF, UK
About the event
Presentation with Q&A followed by wine and canapes
The company presentation will cover a brief history of the group, its current shape and changes since Emma Walmsley became CEO in 2017. There will then be an overview of the Pharmaceutical & Vaccines business looking at the challenges and the opportunities going forward. This will be followed by an overview of the Consumer Healthcare business looking at the new JV with Pfizer and the strategy to build power brands through innovation.
The presentation will finish with the latest financial performance, guidance and dividend prospects.